Bodenrader Mark
Officer at Cerevel Therapeutics Holdings, Inc.
- Sold, on record
- $389k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Dec 20, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Cerevel Therapeutics Holdings, Inc.RoutineJun 2, 2023 2023
Sold 1,895 shares at $32.95 ($62k)
Bodenrader Mark, Officer
10b5-1 planSold 25.5% of holdings ($244k position)5,522 shares leftFirst sale on recordFiling
- 2 Form 144 notice Cerevel Therapeutics Holdings, Inc.NoticeJun 5, 2023 +3 days
Filed to sell 1,895 shares ($62k)
Bodenrader Mark, Officer
No 10b5-1 planFiling
- 3 Form 4 sale Cerevel Therapeutics Holdings, Inc.UnusualDec 20, 2023 +198 days
Sold 7,889 shares at $41.42 ($327k)
Bodenrader Mark, Officer
No 10b5-1 planSold 30.8% of holdings ($1.1M position)17,724 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2023 | Dec 21, 2023 | Cerevel Therapeutics Holdings, Inc. | Officer | Form 4 sale | 7,889 | $327k | 30.8% | Unusual | SEC |
| Jun 5, 2023 | Jun 5, 2023 | Cerevel Therapeutics Holdings, Inc. | Officer | Form 144 notice | 1,895 | $62k | Notice | SEC | |
| Jun 2, 2023 | Jun 5, 2023 | Cerevel Therapeutics Holdings, Inc. | Officer | Form 4 sale | 1,895 | $62k | 25.5% | Routine | SEC |